The era of rampant price-cutting in generics is ending. In the wave of consolidation among brand and generics companies that continued in 1995, many of the marginal generics companies that are often the source for the best prices were purchased by innovator drug companies. Among the half-dozen remaining independent generics companies, generic drug prices will stabilize, said industry sources. Generics firms such as Mylan, Barr, Lemon, Watson and Schein will broaden the scope of their ...
REGISTER TO VIEW THIS ARTICLE - Register for a Free Account
Why Register for FREE?
Registering for content on Supermarket News will give you INSTANT access to invaluable articles and media content that industry professionals rely on. You will have access to our special reports, feature articles, and industry analysis. It’s FREE, easy and quick. What are you waiting for! In addition you will also receive complimentary access to the SN salary survey data tables.
Attention Paid Print Subscribers: While you have already been granted free access to SN we ask that you register now. We promise it will only take a few minutes! Or visit your profile and add your print magazine account number and zip code.